Cilengitide is a cyclic peptide based on the sequence cyclo(Arg-Gly-Asp-D-Phe-Val), designed as a research compound for studying αv integrins. It is primarily investigated for its role in angiogenesis and tumor biology, particularly in the context of glioblastoma research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 137813-35-5
Cyclo(RGDfC)
research compound
Cyclic RGDFK peptide
research compound
Cilengitide
research reagent
Alintegimod
pharmaceutical raw material
Valsartan
pharmaceutical raw material
Alanine Valsartan
pharmaceutical raw material
D-valsartan
pharmaceutical raw material
2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid
YYQUWEHEBOMRPH-NYUBLWNDSA-N
CC(C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N